CUSIP: 630104AB3
What is CUSIP 630104AB3?
CUSIP 630104AB3 identifies 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 630104AB3:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2021 Q4 | $0 | $0 | -$4,450,000 | 0 | |
| 2021 Q3 | $4,500,000 | $4,450,000 | 98.89% | 1 | |
| 2021 Q2 | $4,500,000 | $4,480,000 | -$61,151,563 | 99.56% | 1 |
| 2021 Q1 | $54,772,240 | $65,571,563 | -$11,763,239,962 | 98.22% | 5 |
| 2020 Q4 | $67,000,000 | $64,148,250 | +$13,345,245 | 95.75% | 5 |
| 2020 Q3 | $65,425,000 | $59,738,000 | -$17,084 | 91.63% | 4 |
| 2020 Q2 | $53,185,000 | $47,725,000 | -$102,358 | 90.11% | 5 |
| 2020 Q1 | $53,185,000 | $46,075,000 | -$10,393,401 | 86.94% | 5 |
| 2019 Q4 | $65,160,000 | $44,793,000 | +$123,412 | 68.5% | 5 |
| 2019 Q3 | $65,160,000 | $40,966,000 | +$17,731 | 62.89% | 6 |
| 2019 Q2 | $65,160,000 | $41,984,000 | -$855 | 64.62% | 6 |
| 2019 Q1 | $65,160,000 | $40,574,000 | 61.55% | 6 | |
| 2018 Q4 | $65,160,000 | $38,422,000 | -$52,318 | 59.27% | 6 |
| 2018 Q3 | $67,160,000 | $42,187,000 | -$35,137 | 62.54% | 9 |
| 2018 Q2 | $65,160,000 | $45,339,000 | +$458 | 69.57% | 8 |
| 2018 Q1 | $65,160,000 | $46,789,000 | +$44,779,000 | 71.53% | 8 |